Publication:
Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model.

dc.contributor.authorAydin, Unal
dc.contributor.authorUgurlucan, Murat
dc.contributor.authorGungor, Funda
dc.contributor.authorZiyade, Sedat
dc.contributor.authorInan, Bekir
dc.contributor.authorBanach, Maciej
dc.contributor.authorKalko, Yusuf
dc.contributor.authorYasar, Tahsin
dc.date.accessioned2023-05-16T17:10:01Z
dc.date.available2023-05-16T17:10:01Z
dc.description.abstractVascular intimal hyperplasia is associated with increased mortality and morbidity. The authors investigated the effects of atorvastatin on vascular intimal hyperplasia.
dc.description.abstractRats were divided into 4 groups. Groups 1, 2, and 3 had experimental aortic injury and received intraperitoneal injection of atorvastatin, solvent, or 0.9% NaCl, respectively. Group 4 was a nonintervention (laparotomy only) control group. Animals were sacrificed after 3 weeks. Blood samples and injured aortic segment were analyzed.
dc.description.abstractAtorvastatin administration significantly lowered total and low-density lipoprotein cholesterol levels (P = .012 and P = .001, respectively), intima-media ratio (P = .002), and intimal smooth muscle cell accumulation (P < .05) in group 1. Luminal narrowing in animals in group 1 was significantly lower than that in animals in groups 2 and 3, but was higher than in animals in group 4 (P = .009).
dc.description.abstractAtorvastatin suppresses intimal hyerplasia and aids in intimal regeneration by lowering blood lipids and intimal smooth muscle cell accumulation.
dc.identifier.pubmed18796450
dc.identifier.urihttps://hdl.handle.net/20.500.12645/38291
dc.language.isoen
dc.titleEffects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model.
dspace.entity.typePublication
local.indexed.atPubMed

Files